Targeted and Improved Alzheimer's Disease Drug Development
Published
| Region | Hradec Králové Region |
|---|---|
| Title of the Programme | Research |
| Title of the Project | Targeted and Improved Alzheimer's Disease Drug Development |
| Project Website | https://pahnkelab.eu |
| Number of the Project | TO01000078 |
| Project Promoter | Fakultní nemocnice Hradec Králové |
| Project Partner from Donor State | University of Oslo |
| Czech Partner | Bioinova, s.r.o.
|
| Status | Estimated project duration: 1/2021 - 4/2024 |
| Total Eligible Costs | 1 451 470 EUR |
| Grant | 1 378 705 EUR |
Project description:
The aim of the project is the development of compounds for the treatment of Alzheimer´s disease (AD).
The project will include an approaches of personalized medicine during the development process in the way that novel compounds will be tested in a disease in a dish (DiD) model derived from AD patients.